Diverse feto-maternal presentations of chorioangioma: a case series

Authors

  • Amulya Keragode Guruswamy Department of Obstetrics and Gynecology, PGIMER, Chandigarh, India
  • Mamta Kumari Chaudhary Department of Obstetrics and Gynecology, PGIMER, Chandigarh, India
  • Snigdha Kumari Department of Obstetrics and Gynecology, PGIMER, Chandigarh, India
  • Minakshi Rohilla Department of Obstetrics and Gynecology, PGIMER, Chandigarh, India
  • S. C. Saha Department of Obstetrics and Gynecology, PGIMER, Chandigarh, India
  • Sreedhara B. Chaluvashetty Department of Radiodiagnosis, PGIMER, Chandigarh, Chandigarh, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20253548

Keywords:

Chorioangioma, Intrauterine blood transfusion, Fetal growth restriction

Abstract

Placental chorioangioma is the most common benign non-trophoblastic tumor of the placenta, originating from primitive chorionic mesenchyme and typically being vascular. It has an incidence of 0.6-1% among all pregnancies. The size of the lesion remains the most important factor in prognosis, with small tumors often going unnoticed through the pregnancy without any fetal or maternal complications. Larger lesions (more than 4-5 cm) usually present early in pregnancy and can lead to significant maternal and fetal issues. Late presentation allows more time for fetal maturity and is associated with a lower perinatal mortality rate. Ultrasonography and color Doppler imaging are the main diagnostic tools for placental chorioangioma, showing hypo- and hyper-echoic lesions with vasculature connected to the fetal vascular system. Fetal complications, if they occur, may require intrauterine interventions. We present a series of four cases presenting at different gestational ages with diverse fetal and maternal clinical features and outcomes.

 

Metrics

Metrics Loading ...

References

Guschmann M, Henrich W, Dudenhausen JW. Chorioangiomas-new insights into a well-known problem. II. An immuno-histochemical investigation of 136 cases. J Perinat Med. 2003;31:170-5. DOI: https://doi.org/10.1515/JPM.2003.023

Taori K, Patil P, Attarde V, Singh A, Rangankar V. Chorioangioma of placenta: sonographic features. J Clin Ultrasound. 2008;36:113-5. DOI: https://doi.org/10.1002/jcu.20366

Jauniaux E, Ogle R. Color Doppler imaging in the diagnosis and management of chorioangiomas. Ultrasound Obstet Gynecol. 2000;15:463-7. DOI: https://doi.org/10.1046/j.1469-0705.2000.00127.x

Bashiri A, Furman B, Erez O, Wiznitzer A, Holcberg G, Mazor M. Twelve cases of placental chorioangioma: pregnancy outcome and clinical significance. Arch Gynecol Obstet. 2002;266:53-5. DOI: https://doi.org/10.1007/PL00007501

Haak MC, Oosterhof H, Mouw RJ, Oepkes D, Vandenbussche FP. Pathophysiology and treatment of fetal anemia due to placental chorioangioma. Ultrasound Obstet Gynecol. 1999;14:68-70. DOI: https://doi.org/10.1046/j.1469-0705.1999.14010068.x

Buca D, Lacovella C, Khalil A, Rizzo G, Sirotkina M, Makatsariya A, et al. Perinatal outcome of pregnancies complicated by placental chorioangioma: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2020;55:441-9. DOI: https://doi.org/10.1002/uog.20304

Ma H, Liu Z, Ruan J. Placental chorioangioma and pregnancy outcome: a ten-year retrospective study in a tertiary referral centre. BMC Pregnancy Childbirth. 2023;23:381. DOI: https://doi.org/10.1186/s12884-023-05719-x

Salomon LJ, Alfirevic Z, Berghella V, Bilardo C, Hernandez-Andrade E, Johnsen SL, et al. ISUOG Clinical Standards Committee. Practice guidelines for performance of the routine mid-trimester fetal ultrasound scan. Ultrasound Obstet Gynecol. 2011;37:116-26. DOI: https://doi.org/10.1002/uog.8831

Iacovella C, Chandrasekaran N, Khalil A, Bhide A, Papageorghiou A, Thilaganathan B. Fetal and placental vascular tumors: persistent fetal hyperdynamic status predisposes to poorer long-term neurodevelopmental outcome. Ultrasound Obstet Gynecol. 2014;43:658-61. DOI: https://doi.org/10.1002/uog.13272

Escribano D, Galindo A, Arbues J, Puente JM, Fuente PD. Prenatal management of placental chorioangioma: value of the middle cerebral artery peak systolic velocity. Fetal Diagn Ther. 2006;21:489-93. DOI: https://doi.org/10.1159/000095659

As AK, Hagen P, Webb JB, Wijesinghe D. Therapeutic amnio-drainage in chorioangioma. J Obstet Gynecol. 1997;17:169-70. DOI: https://doi.org/10.1080/01443619750113799

Gajewska K, Herinckx A, Holoye A, D’Haene N, Massez A, Cassart M, et al. Antenatal embolization of a large chorioangioma by percutaneous Glubran 2 injection. Ultrasound Obstet Gynecol. 2010,36:773-5. DOI: https://doi.org/10.1002/uog.8806

Zanardini C, Papageorghiou A, Bhide A, Thilaganathan B. Giant placental chorioangioma: natural history and pregnancy outcome. Ultrasound Obstet Gynecol. 2010;35:332-6. DOI: https://doi.org/10.1002/uog.7451

Downloads

Published

2025-10-29

How to Cite

Keragode Guruswamy, A., Chaudhary, M. K., Kumari, S., Rohilla, M., Saha, S. C., & Chaluvashetty, S. B. (2025). Diverse feto-maternal presentations of chorioangioma: a case series. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 14(11), 3987–3990. https://doi.org/10.18203/2320-1770.ijrcog20253548

Issue

Section

Case Series